Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Open research · Psilocybin & psilocin

Trial pipeline

Track psilocybin trial phases, recruitment, sponsors and registry completion dates with country filters, source links, comparison and free data exports.

Free access · No subscription for research tools or data exports

Filter the development pipeline

Reset

6 trials match this view; 10 reported facilities; 10 have usable coordinates. Latest indexed registry check Nov 19, 2026 02:23 UTC. Country membership uses reported locations, including locations without coordinates; Mapped-facility counts cover all sites of matching trials, including international sites, and require valid coordinates.

Enrollment sum: 260 across 6 records with a reported count. Planned and actual counts are mixed; this is not a count of unique treated participants.

Recorded study-start years

20071
20091
20211
20231
20252

Current indexed registry status

Completed3
Recruiting2
Active, not recruiting1

Reported research conditions

Counts describe indexed registry records, not efficacy or total research activity. A trial can count under several conditions or countries. Unknown dates are excluded from the start-year chart; future years reflect planned starts. Stopped studies may reflect recruitment, funding or strategy and are not automatically treatment failures.

Milestones to investigate

The table is ordered by reported primary completion date. Check whether the registry calls enrollment estimated or actual, when the record was last updated, and whether results have been published. Completion dates are not readout dates; no model-generated success probabilities are assigned.

For late-stage studies, choose PHASE3 above. For studies still underway, choose an exact recruitment status. Use sponsor and country filters to inspect a programme, then save records to compare their designs.

Matching trial records

6 matching registry records. Dates are registry milestones, not promised results announcements.
TrialSponsor and phaseStatusEnrollmentStart / primary completion / completionResearch workflow
Psychopharmacology of Psilocybin in Cancer Patients

NCT00465595

Depressive Symptoms · Anxiety · Cancer
Johns Hopkins University

PHASE2

Completed

Registry updated 2018-07-19

56

ACTUAL

2007-04
2014-12
2016-12
Evidence-guide report · Griffiths et al. · 2016
Effects of Psilocybin on Anxiety and Psychosocial Distress in Cancer Patients

NCT00957359

Cancer
NYU Langone Health

EARLY_PHASE1

Completed

Registry updated 2020-10-20

29

ACTUAL

2009-02
2018-09-06
2018-09-06
A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer

NCT04522804

Cancer
University of Utah

EARLY_PHASE1

Completed

Registry updated 2024-03-20

12

ACTUAL

2021-10-04
2022-06-11
2022-12-16
A Phase 2b Double-blind, Randomized, Low-dose Comparator-controlled Clinical Trial to Assess the Efficacy and Safety of NPX-5 in Psilocybin-assisted Psychotherapy for the Treatment of Adjustment Disorder Associated With Cancer.

NCT07072728

Adjustment Disorder · Adjustment Disorder With Anxious Mood · Cancer · Cancer Cachexia · Cancer of Endometrium · Cancer of Kidney · Cancer of Prostate · Cancer of the Breast · Cancer of Stomach · Cancer Melanoma Skin · Cancer Pancreas
Psyence Australia Pty Ltd

PHASE2

Recruiting

Registry updated 2026-10-29

87

ESTIMATED

2025-10-01
2027-03-30
2027-12-30
TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

NCT06801041

Depression · Anxiety · Cancer
M.D. Anderson Cancer Center

PHASE2

Recruiting

Registry updated 2026-11-03

20

ESTIMATED

2025-05-23
2027-03-31
2029-03-31
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of up to Two Doses of Psilocybin for the Treatment of Major Depressive Disorder in Adults With Cancer

NCT05947383

Cancer · Major Depressive Disorder
Sunstone Medical

PHASE2

Active, not recruiting

Registry updated 2026-05-06

56

ESTIMATED

2023-10-23
2027-04-30
2027-11-01

Reported research facilities

Empax CentreLeederville, Western Australia, Australia · Coordinates available
Mind Medicine Australia ClinicAbbotsford, Victoria, Australia · Coordinates available
NeurocentrixMelbourne, Victoria, Australia · Coordinates available
Paratus Clinical Research MelbourneNorthcote, Victoria, Australia · Coordinates available
Ramsay Northside ClinicMelbourne, Victoria, Australia · Coordinates available
Behavioral Pharmacology Research Unit, Johns Hopkins Bayview CampusBaltimore, Maryland, United States · Coordinates available
Huntsman Cancer InstituteSalt Lake City, Utah, United States · Coordinates available
NYU College of Dentistry Bluestone Center for Clinical ResearchNew York, New York, United States · Coordinates available
Sunstone Medical, PCRockville, Maryland, United States · Coordinates available
The University of Texas M. D. Anderson Cancer CenterHouston, Texas, United States · Coordinates available

This directory includes reported facilities with and without coordinates. For a country-filtered view, locations are labeled as selected-country sites or international sites of matching trials. Facilities are registry-reported trial sites, not an independently verified clinic or research-centre directory. Current services and contact details must be checked at the source.